CARNOUSTIE PHARMA LTD
Opportunity 70/100 (strong), bankability 65/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (55/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 incorporation
- • 1 incorporation
Corporate timeline (5 events)Click to expand
- 2026-03-16🏢Company incorporatedAs CARNOUSTIE PHARMA LTD
- 2026-03-16➕KAZAM, Syed Ali appointeddirector
- 2026-03-16➕KHAN, Mohammed Idreece appointeddirector
- 2026-03-16➕YOUNIS, Zain appointeddirector
- 2026-03-16📄incorporation-companyincorporation · NEWINC
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Young company: Only 0.2 years old — management layer unlikely to be developed.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
Red flags
cleanShareholders & ownership
3 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Syed Ali Kazam Individual · British · DOB 10/1995 · age 31 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 16/03/2026 |
Mr Mohammed Idreece Khan Individual · British · DOB 04/1992 · age 34 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 16/03/2026 |
Mr Zain Younis Individual · British · DOB 09/1995 · age 31 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 16/03/2026 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| JEWISH CARE SCOTLAND→ SC179994 · est 1997 · no financials extracted | — | — | — | — | 28y | — | — |
| KJL ORTHOPAEDICS LTD→ SC760603 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| LIBERIAUXILIUM LIMITED→ SC749749 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| LOGAN HEALTHCARE LTD→ SC383809 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| LOTHIAN HOMECARE LTD→ SC773776 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| LOTHIAN INDEPENDENT PRACTITIONERS LIMITED→ SC165965 · est 1996 · no financials extracted | — | — | — | — | 29y | — | — |
| LOUISE MURRAY PHYSIO LTD→ SC818136 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| LP COUNSELLING AND PSYCHOTHERAPY LTD→ SC816093 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| LR NUTRITION LIMITED→ SC850046 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| LST PROFESSIONALS LIMITED→ SC540225 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| LUNGETIA LTD→ SC880351 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| LUTHCO LTD→ SC849167 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 0 resigned)
Click a director name to see their full track record across all companies.